Phio Pharmaceuticals: Navigating Financial Volatility Amid Biotech Innovations
Phio Pharmaceuticals Corp’s stock has experienced significant volatility, with a 52-week high nearly ten times its current value, raising concerns about the company’s financial health and potential undervaluation.
2 minutes to read